, Fox Chase Cancer Center, discovered the hepatitis B virus for which he won the Nobel Prize.
Buckminster Fuller, Baruch Blumberg
, Kary Mullis, K.
, a Nobel Prize-winning scientist who discovered the hepatitis B virus and subsequently developed a preventive vaccine that saved millions of lives, died Tuesday.
Discovery of the hepatitis B virus (HBV) earned Baruch Blumberg
, MD, PhD, the Nobel Prize in 1976 and opened an exciting era of research that yielded breakthrough tests for HBV that are widely used today in blood-donor screening and patient diagnosis and management.
, Nobel Laureate, co-discoverer of the hepatitis B virus and co-inventor of the hepatitis B vaccine - Prof.
, curious about inherited traits disease susceptibility, and his team traveled the world, collecting different blood samples from native populations in remote areas.
A team of scientists comprised of Nathaniel Szewczyk, Rocco Mancinelli, and Catharine Conley from the NASA Ames Research Center (Moffett Field, CA), William McLamb and David Reed from Bionetics Corporation (Kennedy Space Center, FL) and Nobel Laureate Baruch Blumberg
from Fox Chase Cancer Center have co-authored a paper entitled, "Caenorhabditis elegans Survives Atmospheric Breakup of STS-107, Space Shuttle Columbia" that documents the amazing recovery of the experimental worms, which are commonly used in biological studies and are being developed as a model system for space biology research.
who, in 1976, won the Nobel Prize in medicine for his discovery of the hepatitis B virus.
, who won the Nobel Prize for his discovery of the hepatitis B virus, and with his active support, the Foundation grew from a grassroots effort into a national nonprofit research and disease advocacy organization with a global reach.
This year's speakers by order of presentation are: Nobel Laureate in Medicine Baruch Blumberg
Members of SAB include Baruch Blumberg
(Nobel laureate and the discoverer of hepatitis B virus), Brian Morgan (previously VP & Director of Licensing at SmithKline Beecham and currently director of D-Pharm, KS Biomedix and Scottish Biomedical) and Jeffery Robinson (formally Group Director of Molecular & Cellular Biology at SmithKline Beecham and currently Chairman of BioActa).
Two of Synergy's top scientific experts, Nobel Laureate Baruch Blumberg
and Oxford GlycoSciences plc co-founder Raymond Dwek, agreed to join Unither Pharmaceutical's Scientific Advisory Board.